Literature DB >> 27367466

Inactivation and Environmental Stability of Zika Virus.

Janis A Müller, Mirja Harms, Axel Schubert, Stephanie Jansen, Detlef Michel, Thomas Mertens, Jonas Schmidt-Chanasit, Jan Münch.   

Abstract

Entities:  

Keywords:  Flavivirus; Zika virus; inactivation; vector-borne infections; viruses

Mesh:

Substances:

Year:  2016        PMID: 27367466      PMCID: PMC4994368          DOI: 10.3201/eid2209.160664

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Zika virus is an emerging virus that has spread to most countries in Latin America and the Caribbean (,). It is transmitted by mosquitoes and through sexual intercourse (). Most persons infected with Zika virus are asymptomatic or experience mild symptoms (). However, in a pregnant woman, infection may cause severe pregnancy and birth complications, most notably microcephaly in children infected in utero (–). Zika virus infection might also be associated with an increased incidence of Guillain-Barré syndrome (). Thus, the virus represents a threat to healthcare workers who manage infected patients or diagnostic samples and researchers who work with infectious virus in laboratories. Working with Zika virus, a Biosafety Level 2 (BSL-2) pathogen in the European Union, except for the United Kingdom (where it is BSL-3), requires specific safety precautions (). No inactivation data specific for Zika virus are available (); consequently, disinfection guidelines are based on protocols to inactivate other flaviviruses. To gain experimental evidence regarding inactivation and disinfection for Zika virus, we determined its susceptibility to various disinfectants and inactivation methods. To test susceptibilities, we determined the 50% tissue cell infectious dose per milliliter (TCID50/mL) () of the Zika virus MR766 strain () before and after the virus was exposed to disinfectants or other inactivation procedures (Technical Appendix). We then determined the effect of alcohol-based disinfectants on viral infectivity. Using Zika virus stock containing 2.5% fetal calf serum (FCS) mixed 3:10 (vol/vol) with indicated alcohols, we incubated the mixture for 1 minute and then used it for infection (Figure, panel A). All alcohols entirely inactivated the virus. Complete loss of infectivity was also observed after virus exposure to 1% hypochlorite (often used to inactivate virus in liquid wastes in BSL-2/3 laboratories), 2% paraformaldehyde (used to inactivate virus for subsequent flow cytometry), and 2% glutaraldehyde (often applied to fix virus for subsequent electron microscopy analysis) (Figure, panel A). Thus, routinely used disinfectants and inactivation procedures are sufficient to inactivate Zika virus in laboratory virus stocks. Next, we repeated these experiments in the presence of a high protein load using Zika virus preparations supplemented with FCS in increasing concentrations (10%, 40%, 90%), to mimic virus found in clinically relevant material. Again, all treatments entirely disrupted Zika virus infectivity (Figure, panel A).
Figure

Inactivation and environmental stability of Zika virus. Asterisks (*) indicate lack of infection. A) Virus stocks containing 2.5%, 10%, 40%, or 90% fetal calf serum were incubated with alcohol-based disinfectants for 1 min. All disinfectants inactivated the virus. B) Virus stocks containing indicated concentrations of fetal calf serum were exposed to the ultraviolet (UV) light of a laminar flow hood. Higher concentrations of serum required more time to inactivate the virus. C) Virus stock was dried for 18 h and was then reconstituted in medium or the indicated disinfectants for 5 min or exposed to 10 min UV light before reconstitution. All disinfectants inactivated the virus. D) Virus was dried and incubated for indicated periods of time. Thereafter, dried virus was reconstituted in medium or 70% (vol/vol) isopropanol. Isopropanol inactivated the virus, but dried virus in medium remained infectious even after 84 h of incubation. E) Zika virus was incubated for 5 min at indicated temperatures. Temperatures >60°C inactivated the virus. F) Stocks were adjusted to indicated pH values and incubated for 10 min. pH levels <4 or >11 deactivated the virus. G) Finger tips of laboratory gloves were cut off, with or without introducing a hole by pinching with a needle, and put into medium. Glove tips were filled with virus stock and incubated for 90 min at room temperature. All gloves without needle holes were protective against transmission; 2 of 3 gloves with needle holes allowed virus transmission. For detailed experimental description, see Technical Appendix. DMSO, dimethyl sulfoxide; E, ethanol; G, glutaraldehyde; H, hypochlorite; I, incidin, IP, isopropanol; M, medium, M+, medium plus 10 min UV; ND, not dried; PBS, phosphate-buffered saline; PF, paraformaldehyde; TCID50, 50% tissue culture infective dose; UV, ultraviolet.

Inactivation and environmental stability of Zika virus. Asterisks (*) indicate lack of infection. A) Virus stocks containing 2.5%, 10%, 40%, or 90% fetal calf serum were incubated with alcohol-based disinfectants for 1 min. All disinfectants inactivated the virus. B) Virus stocks containing indicated concentrations of fetal calf serum were exposed to the ultraviolet (UV) light of a laminar flow hood. Higher concentrations of serum required more time to inactivate the virus. C) Virus stock was dried for 18 h and was then reconstituted in medium or the indicated disinfectants for 5 min or exposed to 10 min UV light before reconstitution. All disinfectants inactivated the virus. D) Virus was dried and incubated for indicated periods of time. Thereafter, dried virus was reconstituted in medium or 70% (vol/vol) isopropanol. Isopropanol inactivated the virus, but dried virus in medium remained infectious even after 84 h of incubation. E) Zika virus was incubated for 5 min at indicated temperatures. Temperatures >60°C inactivated the virus. F) Stocks were adjusted to indicated pH values and incubated for 10 min. pH levels <4 or >11 deactivated the virus. G) Finger tips of laboratory gloves were cut off, with or without introducing a hole by pinching with a needle, and put into medium. Glove tips were filled with virus stock and incubated for 90 min at room temperature. All gloves without needle holes were protective against transmission; 2 of 3 gloves with needle holes allowed virus transmission. For detailed experimental description, see Technical Appendix. DMSO, dimethyl sulfoxide; E, ethanol; G, glutaraldehyde; H, hypochlorite; I, incidin, IP, isopropanol; M, medium, M+, medium plus 10 min UV; ND, not dried; PBS, phosphate-buffered saline; PF, paraformaldehyde; TCID50, 50% tissue culture infective dose; UV, ultraviolet. Ultraviolet (UV) radiation inactivates viruses by chemically modifying the genome. We exposed 200 μL of Zika virus preparations containing increasing concentrations of serum to UV light of a laminar flow for up to 60 minutes. Exposure for 10 minutes entirely inactivated Zika virus in the presence of 2.5% FCS serum; increasing concentrations of serum reduced the antiviral effects of UV light (Figure, panel B). When Zika virus containing 90% serum was exposed for 60 min to UV light, infectivity was reduced by 99.95%; however, some residual infectivity was detected (Figure, panel B). Next, we evaluated environmental stability by drying 100 μL of Zika virus stock for 18 hours. Thereafter, dried virus was reconstituted in the same volume of medium or disinfectants. Endpoint titrations showed that the reconstituted virus remained infectious, although TCID50 was reduced by ≈3 orders of magnitude (Figure, panel C). All disinfectants and UV radiation entirely inactivated dried Zika virus (Figure, panel C). Additional experiments demonstrated that dried Zika virus remained infectious for >3 days (Figure, panel D) suggesting, for example, that dried droplets can be infectious, confirming that proper surface disinfection is essential. We also assessed the environmental stability of Zika virus to heat and change in pH. The virus was stable at temperatures up to 50°C but lost all infectivity at temperatures of >60°C (Figure, panel E). Thus, virus-contaminated materials such as surgical instruments can be decontaminated by heat. We also found that Zika virus infectivity was highest after adjusting the stock to a pH of ≈9 (Figure, panel F). In contrast, adjusting Zika virus to pH 12 or to Finally, we analyzed whether gloves routinely used in BSL-2 laboratories protect against Zika virus. For this, we cut off fingertips of nitrile and latex gloves, filled tips with a Zika virus suspension, and placed them into cell culture plates containing medium. Virus-containing fingertips were inserted in such a way that diffusion would only occur if the virus passed through the nitrile/latex barrier. As a control, we made a hole of <1 mm in the fingertips. All 3 tested gloves prevented virus diffusion (Figure, panel G). However, if glove integrity was disrupted by a pin, the virus passed through in 2 of 3 cases (Figure, panel G). We demonstrated that Zika virus is destroyed by classical disinfectants and inactivation methods and that nitrile and latex gloves are protective. We also showed that UV light of a laminar flow hood inactivates Zika virus, but particularly if the virus is in a protein-rich environment, the exposure time range should be in hours rather than in minutes. Although we expected that Zika virus would be inactivated by alcohol and disinfectants, we conducted a thorough experimental verification to exclude uncertainties surrounding work with this emerging pathogen.

Technical Appendix

Methods of testing susceptibility of Zika virus to various disinfectants and inactivation methods.
  8 in total

1.  Zika virus. I. Isolations and serological specificity.

Authors:  G W A DICK; S F KITCHEN; A J HADDOW
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

2.  Zika virus infection in a traveller returning to Europe from Brazil, March 2015.

Authors:  L Zammarchi; D Tappe; C Fortuna; M E Remoli; S Günther; G Venturi; A Bartoloni; J Schmidt-Chanasit
Journal:  Euro Surveill       Date:  2015-06-11

3.  Zika Virus and Birth Defects--Reviewing the Evidence for Causality.

Authors:  Sonja A Rasmussen; Denise J Jamieson; Margaret A Honein; Lyle R Petersen
Journal:  N Engl J Med       Date:  2016-04-13       Impact factor: 91.245

4.  Evidence of Sexual Transmission of Zika Virus.

Authors:  Eric D'Ortenzio; Sophie Matheron; Yazdan Yazdanpanah; Xavier de Lamballerie; Bruno Hubert; Géraldine Piorkowski; Marianne Maquart; Diane Descamps; Florence Damond; Isabelle Leparc-Goffart
Journal:  N Engl J Med       Date:  2016-04-13       Impact factor: 91.245

5.  Zika virus detection in urine from patients with Guillain-Barré syndrome on Martinique, January 2016.

Authors:  Benoît Rozé; Fatiha Najioullah; Jean-Louis Fergé; Kossivi Apetse; Yannick Brouste; Raymond Cesaire; Cédric Fagour; Laurence Fagour; Patrick Hochedez; Séverine Jeannin; Julien Joux; Hossein Mehdaoui; Ruddy Valentino; Aïssatou Signate; André Cabié
Journal:  Euro Surveill       Date:  2016

6.  Zika without symptoms in returning travellers: What are the implications?

Authors:  Mylène Ginier; Andreas Neumayr; Stephan Günther; Jonas Schmidt-Chanasit; Johannes Blum
Journal:  Travel Med Infect Dis       Date:  2016-02-05       Impact factor: 6.211

7.  Zika Virus Associated with Microcephaly.

Authors:  Jernej Mlakar; Misa Korva; Nataša Tul; Mara Popović; Mateja Poljšak-Prijatelj; Jerica Mraz; Marko Kolenc; Katarina Resman Rus; Tina Vesnaver Vipotnik; Vesna Fabjan Vodušek; Alenka Vizjak; Jože Pižem; Miroslav Petrovec; Tatjana Avšič Županc
Journal:  N Engl J Med       Date:  2016-02-10       Impact factor: 91.245

8.  Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities.

Authors:  Rita W Driggers; Cheng-Ying Ho; Essi M Korhonen; Suvi Kuivanen; Anne J Jääskeläinen; Teemu Smura; Avi Rosenberg; D Ashley Hill; Roberta L DeBiasi; Gilbert Vezina; Julia Timofeev; Fausto J Rodriguez; Lev Levanov; Jennifer Razak; Preetha Iyengar; Andrew Hennenfent; Richard Kennedy; Robert Lanciotti; Adre du Plessis; Olli Vapalahti
Journal:  N Engl J Med       Date:  2016-03-30       Impact factor: 91.245

  8 in total
  23 in total

1.  Temperature sensitivity and environmental stability of Chandipura virus.

Authors:  A B Sudeep; R S Gunjikar; Y S Ghodke; K Khutwad; G N Sapkal
Journal:  Virusdisease       Date:  2019-01-19

2.  Comparative analysis of viral entry for Asian and African lineages of Zika virus.

Authors:  Nicholas Rinkenberger; John W Schoggins
Journal:  Virology       Date:  2019-04-25       Impact factor: 3.616

Review 3.  Zika virus epidemiology: from Uganda to world pandemic, an update.

Authors:  C Talero-Gutiérrez; A Rivera-Molina; C Pérez-Pavajeau; I Ossa-Ospina; C Santos-García; M C Rojas-Anaya; A de-la-Torre
Journal:  Epidemiol Infect       Date:  2018-03-14       Impact factor: 4.434

4.  Detection of Zika Virus in Desiccated Mosquitoes by Real-Time Reverse Transcription PCR and Plaque Assay.

Authors:  Kristen L Burkhalter; Harry M Savage
Journal:  Emerg Infect Dis       Date:  2017-04-15       Impact factor: 6.883

5.  Preconceptual Zika virus asymptomatic infection protects against secondary prenatal infection.

Authors:  Lucien H Turner; Jeremy M Kinder; Adrienne Wilburn; Rahul J D'Mello; Makayla R Braunlin; Tony T Jiang; Giang Pham; Sing Sing Way
Journal:  PLoS Pathog       Date:  2017-11-16       Impact factor: 6.823

Review 6.  Preventive and therapeutic challenges in combating Zika virus infection: are we getting any closer?

Authors:  Meera V Singh; Emily A Weber; Vir B Singh; Nicole E Stirpe; Sanjay B Maggirwar
Journal:  J Neurovirol       Date:  2017-01-23       Impact factor: 2.643

7.  Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses.

Authors:  Anindya Siddharta; Stephanie Pfaender; Nathalie Jane Vielle; Ronald Dijkman; Martina Friesland; Britta Becker; Jaewon Yang; Michael Engelmann; Daniel Todt; Marc P Windisch; Florian H Brill; Joerg Steinmann; Jochen Steinmann; Stephan Becker; Marco P Alves; Thomas Pietschmann; Markus Eickmann; Volker Thiel; Eike Steinmann
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

8.  Development of a high-throughput colorimetric Zika virus infection assay.

Authors:  Janis A Müller; Mirja Harms; Axel Schubert; Benjamin Mayer; Stephanie Jansen; Jean-Philippe Herbeuval; Detlef Michel; Thomas Mertens; Olli Vapalahti; Jonas Schmidt-Chanasit; Jan Münch
Journal:  Med Microbiol Immunol       Date:  2017-02-07       Impact factor: 3.402

9.  Point of sampling detection of Zika virus within a multiplexed kit capable of detecting dengue and chikungunya.

Authors:  Ozlem Yaren; Barry W Alto; Priyanka V Gangodkar; Shatakshi R Ranade; Kunal N Patil; Kevin M Bradley; Zunyi Yang; Nikhil Phadke; Steven A Benner
Journal:  BMC Infect Dis       Date:  2017-04-20       Impact factor: 3.090

10.  Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings.

Authors:  Marek Widera; Sandra Westhaus; Holger F Rabenau; Sebastian Hoehl; Denisa Bojkova; Jindrich Cinatl; Sandra Ciesek
Journal:  Med Microbiol Immunol       Date:  2021-07-01       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.